The Efficacy of Acupressure in Managing Opioid-induced Constipation

Sponsor
Istanbul Aydın University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04876508
Collaborator
Acibadem University (Other), Istanbul University (Other)
120
1
2
10.9
11

Study Details

Study Description

Brief Summary

In a randomized controlled study to evaluate the effect of acupressure application on opioid-related constipation, the Patient Identification Form, Defecation Diary, Visual Analog Scale and Constipation Quality of Life Scale will be applied after obtaining written informed consent from the patients. Patients in the experimental group will be given acupressure once a day for 7 consecutive days. Acupressure application will be applied by researchers who have been trained and certified on this subject. While the patients are in supine position, pressure will be applied to each acupressure point around the navel, respectively, Zhongwan (CV12), Guanyuan (CV4) and Tianshu (ST25) for 2 minutes for a total of 6 minutes. No attempt will be made to the control group. All patients will be followed for a total of 4 weeks and the Defecation Diary and Visual Comparison Scale will be applied weekly. 4. Constipation Quality of Life Scale will be applied again at the end of the week. The study was planned to examine the effect of acupressure on opioid-related constipation.

Condition or Disease Intervention/Treatment Phase
  • Other: Accupressure
N/A

Detailed Description

Constipation symptom, which is very common in patients using opioids, affects the quality of life of the patients and may increase the severity of other symptoms. Pharmacological and non-pharmacological methods can be used in the management of opioid-associated constipation. One of the non-pharmacological approaches used is acupressure application. The effects of acupressure to increase bowel movements have been shown in studies. The study was planned to examine the effect of acupressure on opioid-related constipation. The goals that achieve this goal; To evaluate gastrointestinal functions in patients using opioid drugs, to examine and alleviate the effect of acupressure application on gastrointestinal functions (stool frequency, stool type, abdominal distension, abdominal pain, abdominal tenderness) in these patients, their quality of life (anxiety / anxiety states, physical, psychological discomfort) to evaluate and improve situations, satisfaction situations).

Study Population and Sample The research will be conducted in Istanbul University Istanbul Faculty of Medicine Hospital Algology Outpatient Clinic and Service. The universe of the study will consist of all patients followed in the Algology outpatient clinic and service. The sample of the study will consist of all patients who meet the inclusion criteria and who are willing to participate in the study. The patients enrolled in the study will be divided into intervention and control groups using the previously prepared randomization checklist.

Procedures In a randomized controlled study to evaluate the effect of acupressure application on opioid-related constipation, the Patient Identification Form, Defecation Diary, Visual Comparison Scale and Constipation Quality of Life Scale will be applied after obtaining written informed consent from the patients. Patients in the intervention group will be given acupressure once a day for 7 consecutive days. Acupressure application will be applied by researchers who have been trained and certified on this subject. While the patients are in supine position, pressure will be applied to each acupressure point around the navel, respectively, Zhongwan (CV12), Guanyuan (CV4) and Tianshu (ST25) for 2 minutes for a total of 6 minutes. No attempt will be made to the control group. All patients will be followed for a total of 4 weeks and the Defecation Diary and Visual Comparison Scale will be applied weekly.No intervention will be applied to the control group.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
The Efficacy of Acupressure in Managing Opioid-induced Constipation
Actual Study Start Date :
Aug 1, 2020
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acupressure group

Patients in the acupressure group will be given acupressure once a day for 7 consecutive days. Acupressure application will be applied by researchers who have been trained and certified on this subject. While the patients are in supine position, pressure will be applied to each acupressure point around the navel, respectively, Zhongwan (CV12), Guanyuan (CV4) and Tianshu (ST25) for 2 minutes for a total of 6 minutes.

Other: Accupressure
Patients in the experimental group will be given acupressure once a day for 7 consecutive days. Acupressure application will be applied by researchers who have been trained and certified on this subject. While the patients are in supine position, pressure will be applied to each acupressure point around the navel, respectively, Zhongwan (CV12), Guanyuan (CV4) and Tianshu (ST25) for 2 minutes for a total of 6 minutes.

No Intervention: Control group

No intervention will be applied

Outcome Measures

Primary Outcome Measures

  1. Patient Information Form [Baseline]

    The descriptive characteristics, age, gender, marital status, education status, diagnosis are included. It is 10 items in total.

  2. Defecation diary- the amount of stool [patients will record their defecation status for 4 weeks each time they defecate.]

    None (0) Less (+) (1) Medium (++) (2) It is scored as extra (+++) (3). As the score increases, constipation decreases. Includes a minimum of 0 and a maximum of 3 points.

  3. Defecation diary - stool consistency [patients will record their defecation status for 4 weeks each time they defecate.]

    Small, hard like marble (1 point) Bulky, hard (2 point) Normal (3 point) Soft (4 point) Aqueous (5 point) As the score increases, constipation decreases. Includes a minimum of 1 and a maximum of 5 points.

  4. Defecation diary - straining during defecation [patients will record their defecation status for 4 weeks each time they defecate.]

    Defecation without straining (1) Straining at the beginning of defecation (2) Straining in half defecation (3) Straining during all defecation (4) The higher the score, the higher the severity of constipation. Includes a minimum of 1 and a maximum of 4 points.

  5. Defecation diary - feeling of incomplete emptying after defecation [patients will record their defecation status for 4 weeks each time they defecate.]

    Present after defecation (1) None after defecation (0) The higher the score, the higher the severity of constipation. Includes a minimum of 0 and a maximum of 1 points.

  6. Visual Analog Scale [this assessment on a daily basis, and a one-week total score was obtained for each item]

    Pamuk et al. The form developed by (2003) includes 6 questions about the severity of the constipation symptoms. The Visual Analog Scale is a 10 cm horizontal line with 0 at one end and 10 at the other. The patient will be asked to mark the severity of each of the constipation symptoms on the horizontal line, giving a score between 0 and 10. The patients made this assessment daily, and by adding the scores, the total score average for one week for each item will be obtained. Minimum 0 Maximum 60 points are obtained from the scale. As the score increases, the severity of constipation increases.

  7. Constipation Quality of Life Scale [Baseline and at the end of the fourth week]

    It will be used in order to determine the effects of constipation related to opioid treatment on daily life and to measure the quality of life. The highest score that can be obtained from the scale is 140 and the lowest score is 28. It is thought that as the scores obtained from the scale increase, the quality of life is also negatively affected.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged 18 and over who agreed to participate in the study,

  • Cooperative and have no communication problem,

  • Who have been on opioid therapy for at least 2 weeks,

  • Can be fed orally,

  • Constipation diagnosed by the physician,

  • Patients whose constipation continues despite receiving laxative therapy for at least 1 week

Exclusion Criteria:
  • Diagnosed with a known psychiatric illness (delirium, anxiety, panic attack, depression)

  • Have thrombocytopenia (thrombocyte count <50,000 / μL),

  • Have a gastrointestinal tumor,

  • Having a history of abdominal hernia, bowel cancer and abdominal surgery,

  • Having intraabdominal infection,

  • Have irritable bowel syndrome and intestinal obstruction,

  • Patients with inflammatory bowel disease will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul Aydin University Istanbul Turkey

Sponsors and Collaborators

  • Istanbul Aydın University
  • Acibadem University
  • Istanbul University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
DİLEK YILDIRIM, Assistant Professor, Istanbul Aydın University
ClinicalTrials.gov Identifier:
NCT04876508
Other Study ID Numbers:
  • OPIOID-INDUCED CONSTIPATION
First Posted:
May 6, 2021
Last Update Posted:
May 6, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by DİLEK YILDIRIM, Assistant Professor, Istanbul Aydın University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2021